These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 10530680)

  • 1. Gabapentin as adjunctive therapy for partial seizures.
    Bruni J
    Epilepsia; 1999; 40 Suppl 6():S27-8; discussion S73-4. PubMed ID: 10530680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and tolerability of gabapentin as adjunctive therapy in a large, multicenter study.
    McLean MJ; Morrell MJ; Willmore LJ; Privitera MD; Faught RE; Holmes GL; Magnus-Miller L; Bernstein P; Rose-Legatt A
    Epilepsia; 1999 Jul; 40(7):965-72. PubMed ID: 10403221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome evaluation of gabapentin as add-on therapy for partial seizures. "NEON" Study Investigators Group. Neurontin Evaluation of Outcomes in Neurological Practice.
    Bruni J
    Can J Neurol Sci; 1998 May; 25(2):134-40. PubMed ID: 9604135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AUStralian study of titration to effect profile of safety (AUS-STEPS): high-dose gabapentin (neurontin) in partial seizures.
    Beran R; Berkovic S; Black A; Danta G; Dunne J; Frasca J; Grainger K; Kilpatrick C; McKenzie R; McLaughlin D; Schapel G; Somerville E
    Epilepsia; 2001 Oct; 42(10):1335-9. PubMed ID: 11737169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gabapentin monotherapy: II. A 26-week, double-blind, dose-controlled, multicenter study of conversion from polytherapy in outpatients with refractory complex partial or secondarily generalized seizures. The US Gabapentin Study Group 82/83.
    Beydoun A; Fischer J; Labar DR; Harden C; Cantrell D; Uthman BM; Sackellares JC; Abou-Khalil B; Ramsay RE; Hayes A; Greiner M; Garofalo E; Pierce M
    Neurology; 1997 Sep; 49(3):746-52. PubMed ID: 9305335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gabapentin used in 559 patients with partial seizures. A multicenter observation study. Spanish Gabapentin Work Group].
    Herranz JL; Sol JM; Hernández G
    Rev Neurol; 2000 Jun 16-30; 30(12):1141-5. PubMed ID: 10935239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monotherapy trials with gabapentin for partial epilepsy.
    Beydoun A
    Epilepsia; 1999; 40 Suppl 6():S13-6; discussion S73-4. PubMed ID: 10530677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of gabapentin therapy in children with refractory partial seizures.
    Khurana DS; Riviello J; Helmers S; Holmes G; Anderson J; Mikati MA
    J Pediatr; 1996 Jun; 128(6):829-33. PubMed ID: 8648543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gabapentin.
    Morris GL
    Epilepsia; 1999; 40 Suppl 5():S63-70. PubMed ID: 10530696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures. International Gabapentin Monotherapy Study Group 945-77.
    Chadwick DW; Anhut H; Greiner MJ; Alexander J; Murray GH; Garofalo EA; Pierce MW
    Neurology; 1998 Nov; 51(5):1282-8. PubMed ID: 9818846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conversion to high dose gabapentin monotherapy in patients with medically refractory partial epilepsy.
    Beydoun A; Fakhoury T; Nasreddine W; Abou-Khalil B
    Epilepsia; 1998 Feb; 39(2):188-93. PubMed ID: 9577999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The long-term safety and efficacy of gabapentin (Neurontin) as add-on therapy in drug-resistant partial epilepsy. The US Gabapentin Study Group.
    Epilepsy Res; 1994 May; 18(1):67-73. PubMed ID: 8088258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gabapentin versus lamotrigine monotherapy: a double-blind comparison in newly diagnosed epilepsy.
    Brodie MJ; Chadwick DW; Anhut H; Otte A; Messmer SL; Maton S; Sauermann W; Murray G; Garofalo EA;
    Epilepsia; 2002 Sep; 43(9):993-1000. PubMed ID: 12199724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of gabapentin as adjunctive therapy in a large, multicenter study. The Steps Study Group.
    Morrell MJ; McLean MJ; Willmore LJ; Privitera MD; Faught RE; Holmes GL; Magnus L; Bernstein P; Rose-Legatt
    Seizure; 2000 Jun; 9(4):241-8. PubMed ID: 10880282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy and tolerability of dose-escalation with generic gabapentin--a multicenter, non-interventional study].
    Rejdak K; Lipa A; Kaczyński K; Stelmasiak Z;
    Wiad Lek; 2011; 64(2):91-6. PubMed ID: 22026272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gabapentin in 50 patients with epilepsy].
    Gracia-Fleta F; Medrano-Martínez V; Castaño-Pérez MD; Hernández-Lorido R; Mañes R
    Rev Neurol; 2001 Jan 1-15; 32(1):45-9. PubMed ID: 11293098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gabapentin (Neurontin) as add-on therapy in patients with partial seizures: a double-blind, placebo-controlled study. The International Gabapentin Study Group.
    Anhut H; Ashman P; Feuerstein TJ; Sauermann W; Saunders M; Schmidt B
    Epilepsia; 1994; 35(4):795-801. PubMed ID: 8082624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gabapentin in refractory partial epilepsy--a trial in India.
    Dixit SN; Jain S; Padma MV; Maheshwari MC
    Acta Neurol Scand; 1996; 93(2-3):85-7. PubMed ID: 8741123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid initiation of gabapentin: a randomized, controlled trial.
    Fisher RS; Sachdeo RC; Pellock J; Penovich PE; Magnus L; Bernstein P
    Neurology; 2001 Mar; 56(6):743-8. PubMed ID: 11274308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosing to efficacy with neurontin: the STEPS trial. Study of Titration to Effect Profile of Safety.
    Morrell MJ
    Epilepsia; 1999; 40 Suppl 6():S23-6; discussion S73-4. PubMed ID: 10530679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.